Crestor vs Losartan: Head-to-Head Efficacy for Women's Cardiometabolic Health
Rosuvastatin (Crestor) lowers LDL and CRP; losartan lowers blood pressure and protects kidneys. See how each drug works for women at every life stage.
Read clinical reviewTopic Hub
Cardiometabolic — Head-to-Head Comparisons
22 clinically reviewed articles, written and peer-reviewed by the WomanRx.com Medical Team.
22articles
171keywords mapped
2025-01-28latest review
Explore
Cardiometabolic — Head-to-Head Comparisons library
Showing 22 of 22 clinical reviews.
Crestor vs Repatha: Switching Between Them and What Women Need to Know
Rosuvastatin vs evolocumab compared for women: LDL lowering, ASCVD risk, life-stage dosing, pregnancy safety, and when switching makes clinical sense.
Read clinical reviewCrestor vs Zetia (Rosuvastatin vs Ezetimibe): Head-to-Head Efficacy for Women
Crestor cuts LDL up to 55%; Zetia cuts it ~18%. But which is safer in pregnancy, perimenopause, and PCOS? A women's-health breakdown.
Read clinical reviewLeqvio vs Amlodipine Side Effects: A Women's Head-to-Head Guide
Leqvio (inclisiran) vs amlodipine side-effect profile compared for women. LDL-lowering vs blood pressure. Life-stage, pregnancy, and PCOS guidance included.
Read clinical reviewLeqvio vs Lisinopril Side Effects: A Head-to-Head Profile for Women
Comparing Leqvio (inclisiran) vs lisinopril side effects for women across life stages, including PCOS, perimenopause, pregnancy safety, and LDL-C data.
Read clinical reviewLipitor vs Leqvio: Head-to-Head Efficacy for Women's Cardiovascular Health
Atorvastatin vs inclisiran efficacy compared for women. Learn which lowers LDL more, how each works across life stages, and pregnancy/lactation safety.
Read clinical reviewLipitor vs Losartan: Cost, Access, and What Actually Matters for Women
Atorvastatin and losartan treat different cardiometabolic problems. This women-health guide compares cost, access, safety in pregnancy, and which drug fits your life stage.
Read clinical reviewLipitor vs Repatha: Head-to-Head Efficacy for Women
Atorvastatin vs evolocumab compared for LDL lowering, cardiovascular outcomes, and women-specific safety including pregnancy, PCOS, and menopause.
Read clinical reviewLisinopril vs Losartan Side Effects: A Women's Head-to-Head Guide
Lisinopril vs losartan side-effect profile compared for women, covering cough, angioedema, pregnancy risk, PCOS, menopause, and how to choose at every life stage.
Read clinical reviewLosartan vs Amlodipine: Switching Between Them and What Women Need to Know
Comparing losartan vs amlodipine for women across every life stage, including who should switch, pregnancy safety, and hormone interactions.
Read clinical reviewPraluent vs Lisinopril: Cost, Access, and Which One Fits Your Cardiometabolic Picture
Praluent (alirocumab) and lisinopril treat different cardiometabolic targets. Compare costs, evidence, and which option fits your life stage and risk profile.
Read clinical reviewPraluent vs Losartan: Head-to-Head Efficacy, Safety, and Which One Fits Your Life Stage
Alirocumab (Praluent) cuts LDL up to 62%. Losartan lowers blood pressure and protects kidneys. Learn which drug fits your cardiometabolic risk, life stage, and hormonal status.
Read clinical reviewRepatha vs Leqvio Side Effects: A Women's Head-to-Head Guide
Repatha vs Leqvio side-effect profile compared for women. Covers injection-site reactions, pregnancy safety, life-stage dosing, and how to choose.
Read clinical reviewRepatha vs Lisinopril: Head-to-Head Efficacy, Women's-Health Differences, and Which Is Right for You
Repatha (evolocumab) and lisinopril treat different parts of cardiovascular risk. Learn how each works, what the trial data shows for women, and which fits your life stage.
Read clinical reviewRepatha vs Lisinopril: Switching Between Them, What Women Need to Know
Repatha (evolocumab) lowers LDL aggressively; lisinopril controls blood pressure. Learn when women switch, why, and what pregnancy and life stage mean for both.
Read clinical reviewRepatha vs Losartan: Cost, Access, and What Women Need to Know
Repatha and losartan treat different cardiometabolic risks. Compare costs, mechanisms, trial data, and women-specific considerations including pregnancy safety.
Read clinical reviewRepatha vs Losartan: Head-to-Head Efficacy for Women's Heart Health
Repatha (evolocumab) lowers LDL up to 60%; losartan targets blood pressure and protects kidneys. Learn which is right for your life stage and cardiovascular risk.
Read clinical reviewRepatha vs Praluent: Head-to-Head Efficacy for Women
Repatha and Praluent cut LDL by 50-60% and reduce MACE by 15%. See how they compare for women across life stages, including pregnancy safety.
Read clinical reviewZetia vs Losartan Side Effects: A Women's Health Head-to-Head
Compare ezetimibe (Zetia) and losartan side-effect profiles for women across life stages, including pregnancy safety, PCOS, and menopause considerations.
Read clinical reviewZetia vs Losartan: What Women Need to Know Before Switching
Zetia lowers LDL cholesterol; losartan lowers blood pressure. They treat different problems. Learn when each is right for you, and what switching means for your health.
Read clinical reviewZetia vs Praluent: Cost, Access, and Which One Fits Your Life Stage
Ezetimibe (Zetia) costs under $30/month generic; alirocumab (Praluent) runs $500+ but cuts MACE 15%. See which cholesterol drug fits your life stage and budget.
Read clinical reviewZetia vs Repatha: Switching Between Them and What Women Need to Know
Zetia (ezetimibe) vs Repatha (evolocumab): LDL lowering, MACE outcomes, switching strategies, and pregnancy/lactation safety for women at every life stage.
Read clinical review